BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25415528)

  • 1. The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.
    Sherlock JP; Taylor PC; Buckley CD
    Curr Opin Rheumatol; 2015 Jan; 27(1):71-5. PubMed ID: 25415528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
    Schinocca C; Rizzo C; Fasano S; Grasso G; La Barbera L; Ciccia F; Guggino G
    Front Immunol; 2021; 12():637829. PubMed ID: 33692806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
    Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
    Fragoulis GE; Siebert S; McInnes IB
    Annu Rev Med; 2016; 67():337-53. PubMed ID: 26565676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL-17 and Th17 cells in rheumatoid arthritis.
    Sarkar S; Fox DA
    Rheum Dis Clin North Am; 2010 May; 36(2):345-66. PubMed ID: 20510238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.
    Li H; Tsokos GC
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):31-45. PubMed ID: 33185790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The link between IL-23 and Th17 cell-mediated immune pathologies.
    McGeachy MJ; Cua DJ
    Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL-1 family of cytokines and receptors in rheumatic diseases.
    Dinarello CA
    Nat Rev Rheumatol; 2019 Oct; 15(10):612-632. PubMed ID: 31515542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IL-23-IL-17 axis in inflammatory arthritis.
    Lubberts E
    Nat Rev Rheumatol; 2015 Jul; 11(7):415-29. PubMed ID: 25907700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
    Bridgewood C; Sharif K; Sherlock J; Watad A; McGonagle D
    Immunol Rev; 2020 Mar; 294(1):27-47. PubMed ID: 31957051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 in inflammatory myopathies.
    Tournadre A; Miossec P
    Curr Rheumatol Rep; 2012 Jun; 14(3):252-6. PubMed ID: 22350607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cells: a new therapeutic target in inflammatory dermatoses.
    Asarch A; Barak O; Loo DS; Gottlieb AB
    J Dermatolog Treat; 2008; 19(6):318-26. PubMed ID: 18626814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-35: a new immunomodulator in autoimmune rheumatic diseases.
    Sakkas LI; Mavropoulos A; Perricone C; Bogdanos DP
    Immunol Res; 2018 Jun; 66(3):305-312. PubMed ID: 29749583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting GM-CSF in inflammatory diseases.
    Wicks IP; Roberts AW
    Nat Rev Rheumatol; 2016 Jan; 12(1):37-48. PubMed ID: 26633290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. At the horizon of innovative therapy in rheumatology: new biologic agents.
    Finckh A; Gabay C
    Curr Opin Rheumatol; 2008 May; 20(3):269-75. PubMed ID: 18388517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases.
    Azizi G; Simhag A; El Rouby NM; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):246-54. PubMed ID: 26546892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.